Cited by 2,310Statistical Methods in Clinical TrialsProbability and Statistical ResearchStatistical Methods and Bayesian Inference

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

Discrete sequential boundaries for clinical trials

GORDON LAN, K. K., DEMETS, DAVID L.·1983·Biometrika

DOI 10.1093/biomet/70.3.659

Open this paper in CoChat — free account

Abstract

Pocock (1977), O'Brien & Fleming (1979) and Slud & Wei (1982) have proposed different methods to construct discrete sequential boundaries for clinical trials. These methods require that the total number of decision times be specified in advance. In the present paper, we propose a more flexible way to construct discrete sequential boundaries. The method is based on the choice of a function, α*(t), which characterizes the rate at which the error level α is spent. The boundary at a decision time is determined by α*(t), and by past and current decision times, but does not depend on the future decision times or the total number of decision times.

Integrity signals

Registry

Crossref · 10.1093/biomet/70.3.659

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

A Multiple Testing Procedure for Clinical Trials
O'Brien, P. C., & Fleming, T. R. (1979) · Biometrics · doi:10.2307/2530245 · Cited by 3,311
Group sequential methods in the design and analysis of clinical trials
POCOCK, S. J. (1977) · Biometrika · doi:10.1093/biomet/64.2.191 · Cited by 1,831
Repeated Significance Tests on Accumulating Data
Armitage, P., McPherson, C. K., & Rowe, B. C. (1969) · Journal of the Royal Statistical Society Series A (General) · doi:10.2307/2343787 · Cited by 772
Stochastically curtailed tests in long–term clinical trials
Lan, K. K. G., Simon, R. M., & Halperin, M. (1982) · Sequential Analysis · doi:10.1080/07474948208836014 · Cited by 356
Interim Analyses for Randomized Clinical Trials: The Group Sequential Approach
Pocock, S. (1982) · Biometrics · doi:10.2307/2530298 · Cited by 265
Two-Sample Repeated Significance Tests Based on the Modified Wilcoxon Statistic
SLUD, E. V., & Wei, L. (1982) · Journal of the American Statistical Association · doi:10.1080/01621459.1982.10477899 · Cited by 244
Crossing probabilities for a square root boundary by a bessel process
Long, D. M. D. (1981) · Communication in Statistics- Theory and Methods · doi:10.1080/03610928108828182 · Cited by 135
Sequential Testing of the Equality of Two Survival Distributions Using the Modified Savage Statistic
Koziol, J. A., & Petkau, A. J. (1978) · Biometrika · doi:10.1093/biomet/65.3.615 · Cited by 38
A two sample wilcoxon test for progressively censored data
DAVIS, C. E. (1978) · Communication in Statistics- Theory and Methods · doi:10.1080/03610927808827630 · Cited by 23
Rank order tests for grouped data under progressive censoring
Majumdar, H., & Sen, P. K. (1977) · Communication in Statistics- Theory and Methods · doi:10.1080/03610927708827511 · Cited by 9

Show all 10 references

Sorted by citations

Items 601–700 of 1,001

Trial Sequential Boundaries for Cumulative Meta-Analyses
Miladinović, B., Hozo, I., & Djulbegović, B. (2013) · The Stata Journal Promoting communications on statistics and Stata · doi:10.1177/1536867x1301300106 · Cited by 76
Withdrawal of Cyclosporine or Tacrolimus After Addition of Mycophenolate Mofetil in Patients With Chronic Allograft Nephropathy
Suwelack, B. M., Gerhardt, U., & Hohage, H. (2004) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2004.00404.x · Cited by 76
A Randomized Trial of 2 Different 4‐Drug Antiretroviral Regimens versus a 3‐Drug Regimen, in Advanced Human Immunodeficiency Virus Disease
Fischl, M. A., Ribaudo, H. J., Collier, A. C., Erice, A., Giuliano, M., Dehlinger, M., Eron, J. J., Saag, M. S., Hammer, S. M., Vella, S., et al. (2003) · The Journal of Infectious Diseases · doi:10.1086/377311 · Cited by 75
Effects of Assumption Violations on Type I Error Rate in Group Sequential Monitoring
Proschan, M. A., Follmann, D. A., & Waclawiw, M. A. (1992) · Biometrics · doi:10.2307/2532704 · Cited by 75
Statistical and ethical issues in monitoring clinical trials
Pocock, S. (1993) · Statistics in Medicine · doi:10.1002/sim.4780121512 · Cited by 75
Prevention of events with angiotensin-converting enzyme inhibition (the PEACE study design)
Pfeffer, M. A., Domanski, M., Rosenberg, Y., Verter, J. I., Geller, N. L., Albert, P., Hsia, J. A., & D, E. B. M. (1998) · The American Journal of Cardiology · doi:10.1016/s0002-9149(98)00488-3 · Cited by 75
The Apnea Positive Pressure Long-term Efficacy Study (APPLES): Rationale, Design, Methods, and Procedures
Kushida, C. A., Nichols, D. A., Quan, S. F., Goodwin, J. L., White, D. P., Gottlieb, D. J., Walsh, J. K., Schweitzer, P. K., Guilleminault, C., Simon, R., et al. (2006) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.26588 · Cited by 74
Point and interval estimation following a sequential clinical trial
Todd, S. (1996) · Biometrika · doi:10.1093/biomet/83.2.453 · Cited by 74
Statistical Considerations for Testing Multiple Endpoints in Group Sequential or Adaptive Clinical Trials
Hung, H., Wang, S., & O’Neill, R. T. (2007) · Journal of Biopharmaceutical Statistics · doi:10.1080/10543400701645405 · Cited by 74
Some Controversial Multiple Testing Problems in Regulatory Applications
Hung, H. M. J., & Wang, S.-J. (2009) · Journal of Biopharmaceutical Statistics · doi:10.1080/10543400802541693 · Cited by 74
Avoidance versus use of neuromuscular blocking agents for improving conditions during tracheal intubation or direct laryngoscopy in adults and adolescents
Lundstrøm, L. H., Duez, C. H. V., Nørskov, A. K., Rosenstock, C. V., Thomsen, J. L., Møller, A. M., Strande, S., & Wetterslev, J. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009237.pub2 · Cited by 73
Efficient Group Sequential Tests with Unpredictable Group Sizes
Jennison, C. (1987) · Biometrika · doi:10.1093/biomet/74.1.155 · Cited by 74
Trial sequential methods for meta‐analysis
Kulinskaya, E., & Wood, J. (2013) · Research Synthesis Methods · doi:10.1002/jrsm.1104 · Cited by 73
Abatacept, Cenicriviroc, or Infliximab for Treatment of Adults Hospitalized With COVID-19 Pneumonia
O’Halloran, J. A., Ko, E. R., Anstrom, K. J., Kedar, E., McCarthy, M. W., Panettieri, R. A., Maillo, M., Nunez, P. S., Lachiewicz, A. M., Gonzalez, C., et al. (2023) · JAMA · doi:10.1001/jama.2023.11043 · Cited by 73
Design of the Trial to Assess Chelation Therapy (TACT)
Lamas, G. A., Goertz, C., Boineau, R., Mark, D. B., Rozema, T. C., Nahin, R. L., Drisko, J., & Lee, K. L. (2011) · American Heart Journal · doi:10.1016/j.ahj.2011.10.002 · Cited by 72
Effect of calcium dobesilate on occurrence of diabetic macular oedema (CALDIRET study): randomised, double-blind, placebo-controlled, multicentre trial
Haritoglou, C., Gerß, J., Sauerland, C., Kampik, A., & ULBIG, M. W. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60218-x · Cited by 72
Interim analysis in clinical trials
Armitage, P. (1991) · Statistics in Medicine · doi:10.1002/sim.4780100613 · Cited by 72
Refractory out‐of‐hospital cardiac arrest and extracorporeal cardiopulmonary resuscitation: A meta‐analysis of randomized trials
Scquizzato, T., Bonaccorso, A., Swol, J., Gamberini, L., Scandroglio, A. M., Landoni, G., & Zangrillo, A. (2023) · Artificial Organs · doi:10.1111/aor.14516 · Cited by 71
Laser Treatment in Patients with Bilateral Large Drusen
(2006) · Ophthalmology · doi:10.1016/j.ophtha.2006.08.015 · Cited by 71
Sequential Monitoring for Comparison of Changes in a Response Variable in Clinical Studies
Wu, M. C., & Lan, K. K. G. (1992) · Biometrics · doi:10.2307/2532343 · Cited by 71
Rationale and Design of a Secondary Prevention Trial of Antibiotic Use in Patients after Myocardial Infarction: The WIZARD (Weekly Intervention with Zithromax [Azithromycin] for Atherosclerosis and Its Related Disorders) Trial
Dunne, M. W. (2000) · The Journal of Infectious Diseases · doi:10.1086/315634 · Cited by 71
FDA Approval Summary: Tremelimumab in Combination with Durvalumab for the Treatment of Patients with Unresectable Hepatocellular Carcinoma
Patel, T. H., Brewer, J. R., Fan, J., Cheng, J., Shen, Y. L., Xiang, Y., Zhao, H., Lemery, S. J., Pazdur, R., Kluetz, P. G., et al. (2023) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-23-2124 · Cited by 70
Epidural versus Continuous Preperitoneal Analgesia during Fast-track Open Colorectal Surgery
Jouve, P., Bazin, J.-É., Petit, A., Minville, V., Gerard, A., Buc, E., Dupré, A., Kwiatkowski, F., Constantin, J., & Futier, E. (2013) · Anesthesiology · doi:10.1097/aln.0b013e3182800d94 · Cited by 70
A New Clinical Trial Design Combining Phases 2 and 3: Sequential Designs with Treatment Selection and a Change of Endpoint
Todd, S., & Stallard, N. (2005) · Drug Information Journal · doi:10.1177/009286150503900201 · Cited by 70
Interventions for preventing high altitude illness: Part 1. Commonly-used classes of drugs
Estrada, V. H. N., Molano-Franco, D., Medina, R. D., Garay, A. G. G., Martí-Carvajal, A. J., & Arévalo-Rodríguez, I. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009761.pub2 · Cited by 70
A randomized, placebo-controlled trial of the safety and efficacy of oral ganciclovir for prophylaxis of cytomegalovirus disease in HIV-infected individuals
Brosgart, C. L., Louis, T. A., Hillman, D. W., Craig, C. P., Alston, B., Fisher, E. J., Abrams, D. I., Luskin‐Hawk, R., Sampson, J. H., Ward, D. J., et al. (1998) · AIDS · doi:10.1097/00002030-199803000-00004 · Cited by 70
Randomised trial of MNrgp120 HIV-1 vaccine in symptomless HIV-1 infection
Eron, J. J., Ashby, M. A., Giordano, M., Chernow, M., Reiter, W. M., Deeks, S. G., Lavelle, J. P., Conant, M. A., Yangco, B. G., Pate, P. G., et al. (1996) · The Lancet · doi:10.1016/s0140-6736(96)05283-x · Cited by 70
Adaptive Designs for Confirmatory Clinical Trials with Subgroup Selection
Stallard, N., Hamborg, T., Parsons, N., & Friede, T. (2014) · Journal of Biopharmaceutical Statistics · doi:10.1080/10543406.2013.857238 · Cited by 69
Phase III Prevention Trial of Fenretinide in Patients with Resected Non–Muscle-Invasive Bladder Cancer
Sabichi, A. L., Lerner, S. P., Atkinson, E. N., Grossman, H. B., Caraway, N. P., Dinney, C. P., Penson, D. F., Matin, S. F., Kamat, A. M., Pisters, L. L., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0733 · Cited by 69
Maintenance daily oral etoposide versus no further therapy following induction chemotherapy with etoposide plus ifosfamide plus cisplatin in extensive small-cell lung cancer:a Hoosier Oncology Group randomized study
Hanna, N. H., Sandler, A. B., Loehrer, P. J., Ansari, R., Jung, S., Lane, K. A., & Einhorn, L. H. (2002) · Annals of Oncology · doi:10.1093/annonc/mdf014 · Cited by 69
Minimum risk weights for comparing treatments in stratified binomial trials
Mehrotra, D. V., & Railkar, R. A. (2000) · Statistics in Medicine · doi:10.1002/(sici)1097-0258(20000330)19:6 · Cited by 44
Testing a Primary and a Secondary Endpoint in a Group Sequential Design
Tamhane, A. C., Mehta, C. R., & Liu, L. (2010) · Biometrics · doi:10.1111/j.1541-0420.2010.01402.x · Cited by 68
The early termination of clinical trials: causes, consequences, and control. With special reference to trials in the field of arrhythmias and sudden death. Task Force of the Working Group on Arrhythmias of the European Society of Cardiology.
(1994) · Circulation · doi:10.1161/01.cir.89.6.2892 · Cited by 68
Cardiac arrest in seattle: Conventional versus amiodarone drug evaluation (the CASCADE study)
The CASCADE Investigators (1991) · The American Journal of Cardiology · doi:10.1016/0002-9149(91)90895-r · Cited by 68
Targeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes mellitus
Hemmingsen, B., Lund, S. S., Gluud, C. N., Vaag, A. A., Almdal, T., Hemmingsen, C., & Wetterslev, J. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008143.pub2 · Cited by 69
Retracted
Challenges and solutions in the design and execution of the PROSPECT Phase II/III neoadjuvant rectal cancer trial (NCCTG N1048/Alliance)
Schrag, D., Weiser, M. R., Saltz, L. B., Mamon, H. J., Gollub, M. J., Basch, E., Venook, A. P., & Shi, Q. (2019) · Clinical Trials · doi:10.1177/1740774518824539 · Cited by 67
Living Systematic Reviews
Simmonds, M. C., Elliott, J., Synnot, A., & Turner, T. (2021) · Methods in molecular biology · doi:10.1007/978-1-0716-1566-9_7 · Cited by 71
Adaptive versus conventional cardiac resynchronisation therapy in patients with heart failure (AdaptResponse): a global, prospective, randomised controlled trial
Wilkoff, B. L., Filippatos, G. S., Leclercq, C., Gold, M. R., Hersi, A. S., Kusano, K., Müllens, W., Felker, G. M., Kantipudi, C., El‐Chami, M. F., et al. (2023) · The Lancet · doi:10.1016/s0140-6736(23)00912-1 · Cited by 68
Interim Monitoring of Group Sequential Trials Using Spending Functions for the Type I and Type II Error Probabilities
Pampallona, S., Tsiatis, A. A., & Kim, K. (2001) · Drug Information Journal · doi:10.1177/009286150103500408 · Cited by 67
Guidelines for Monitoring Efficacy and Toxicity Responses in Clinical Trials
Cook, R. J., & Farewell, V. T. (1994) · Biometrics · doi:10.2307/2533451 · Cited by 67
Evaluating Therapeutic Interventions: Some Issues and Experiences
Fleming, T. R. (1992) · Statistical Science · doi:10.1214/ss/1177011128 · Cited by 67
Guidance on interim analysis methods in clinical trials
Ciolino, J. D., Kaizer, A. M., & Bonner, L. B. (2023) · Journal of Clinical and Translational Science · doi:10.1017/cts.2023.552 · Cited by 66
Using randomization tests to preserve type I error with response adaptive and covariate adaptive randomization
Simon, R. M., & Simon, N. (2011) · Statistics & Probability Letters · doi:10.1016/j.spl.2010.12.018 · Cited by 66
Designs for clinical trials with time-to-event outcomes based on stopping guidelines for lack of benefit
Royston, P. J., Barthel, F. M.-S., Parmar, M., Choodari‐Oskooei, B., & Isham, V. S. (2011) · Trials · doi:10.1186/1745-6215-12-81 · Cited by 66
Is the bispectral index monitoring protective against postoperative cognitive decline? A systematic review with meta-analysis
Bocskai, T., Kovács, M. Á., Szakács, Z., Gede, N., Hegyi, P. J., Varga, G., Pap, I., Tóth, I., Revesz, P. Z., Szanyi, I., et al. (2020) · PLoS ONE · doi:10.1371/journal.pone.0229018 · Cited by 66
Efficient ways exist to obtain the optimal sample size in clinical trials in rare diseases
van der Lee, J. H., Wesseling, J., Tanck, M. W. T., & Offringa, M. (2008) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2007.07.008 · Cited by 65
Designing complex group sequential survival trials
Lakatos, E. (2002) · Statistics in Medicine · doi:10.1002/sim.1193 · Cited by 65
Treatment and secondary prophylaxis with ethanol lock therapy for central line-associated bloodstream infection in paediatric cancer: a randomised, double-blind, controlled trial
Wolf, J., Connell, T. G., Allison, K., Tang, L., Richardson, J. L., Branum, K. C., Borello, E., Rubnitz, J. E., Gaur, A. H., Hakim, H., et al. (2018) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(18)30224-x · Cited by 65
Design of the trial of Org 10172 in acute stroke treatment (TOAST)
Adams, H. P., Woolson, R. F., Clarke, W. R., Davis, P. H., Bendixen, B. H., Love, B. B., Wasek, P. A., & Grimsman, K. J. (1997) · Controlled Clinical Trials · doi:10.1016/s0197-2456(97)00012-3 · Cited by 65
Optimal asymmetric one-sided group sequential tests
Barber, S. (2002) · Biometrika · doi:10.1093/biomet/89.1.49 · Cited by 65
More flexible sequential and non-sequential designs in long-term clinical trial
Lan, K. K. G., Detlets, D. L., & Halperin, M. (1984) · Communication in Statistics- Theory and Methods · doi:10.1080/03610928408828830 · Cited by 65
Alpha, Beta, Meta
Mascha, E. J. (2015) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000000993 · Cited by 65
Design and Rationale of the Reevaluation of Systemic Early Neuromuscular Blockade Trial for Acute Respiratory Distress Syndrome
Huang, D. T., Angus, D. C., Moss, M. M., Thompson, B., Ferguson, N. D., Ginde, A. A., Gong, M. N., Gundel, S. J., Hayden, D. L., Hite, R. D., et al. (2016) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201608-629ot · Cited by 65
Bayesian Hierarchical Modeling for Detecting Safety Signals in Clinical Trials
Xia, H. A., Ma, H., & Carlin, B. P. (2011) · Journal of Biopharmaceutical Statistics · doi:10.1080/10543406.2010.520181 · Cited by 64
Stopping guidelines vs stopping rules: a practitioner's point of view
DeMets, D. L. (1984) · Communication in Statistics- Theory and Methods · doi:10.1080/03610928408828833 · Cited by 64
Self-citation
Design of vaccine efficacy trials during public health emergencies
Dean, N. E., Gsell, P., Brookmeyer, R., Gruttola, V. D., Donnelly, C. A., Halloran, M. E., Jasseh, M., Nason, M., Riveros, X., Watson, C., et al. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aat0360 · Cited by 63
The benefits and risks of menopause hormone therapy for the cardiovascular system in postmenopausal women: a systematic review and meta-analysis
Gu, Y., Han, F., Xue, M., Wang, M., & Huang, Y. (2024) · BMC Women s Health · doi:10.1186/s12905-023-02788-0 · Cited by 83
Prothrombin complex concentrate for reversal of vitamin K antagonist treatment in bleeding and non-bleeding patients
Johansen, M., Wikkelsø, A. J., Lunde, J., Wetterslev, J., & Afshari, A. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010555.pub2 · Cited by 63
A Combination of Esomeprazole and Aspirin Reduces Tissue Concentrations of Prostaglandin E2 in Patients With Barrett's Esophagus
Falk, G. W., Buttar, N. S., Foster, N. R., Ziegler, K. L. A., DeMars, C. J., Romero, Y., Marcon, N. E., Schnell, T. G., Corley, D. A., Sharma, P., et al. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.06.044 · Cited by 63
Applying the law of iterated logarithm to control type I error in cumulative meta-analysis of binary outcomes
Hu, M., Cappelleri, J. C., & Lan, K. K. G. (2007) · Clinical Trials · doi:10.1177/1740774507081219 · Cited by 63
The Effect of Antenatal Phenobarbital Therapy on Neonatal Intracranial Hemorrhage in Preterm Infants
Shankaran, S., Papile, L. A., Wright, L. L., Ehrenkranz, R. A., Mele, L., Lemons, J. A., Korones, S. B., Stevenson, D. K., Donovan, E. F., Stoll, B. J., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199708143370705 · Cited by 63
Dipeptidyl-peptidase (DPP)-4 inhibitors and glucagon-like peptide (GLP)-1 analogues for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk for the development of type 2 diabetes mellitus
Hemmingsen, B., Sonne, D. P., Metzendorf, M.-I., & Richter, B. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012204.pub2 · Cited by 63
The Effect of Higher Protein Dosing in Critically Ill Patients: A Multicenter Registry‐Based Randomized Trial: The EFFORT Trial
Heyland, D. K., Patel, J. J., Bear, D. E., Sacks, G. S., Nixdorf, H., Dolan, J., Aloupis, M., Licastro, K., Jovanović, V., Rice, T. W., et al. (2018) · Journal of Parenteral and Enteral Nutrition · doi:10.1002/jpen.1449 · Cited by 62
Increased risks for random errors are common in outcomes graded as high certainty of evidence
Gartlehner, G., Nußbaumer-Streit, B., Wagner, G., Patel, S. V., Evans, T. S., Dobrescu, A. I., & Gluud, C. N. (2018) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2018.10.009 · Cited by 63
Metformin monotherapy for adults with type 2 diabetes mellitus
Gnesin, F., Thuesen, A. C. B., Kähler, L. K. A., Madsbad, S., & Hemmingsen, B. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012906.pub2 · Cited by 63
Generalized Estimating Equations in Controlled Clinical Trials: Hypotheses Testing
Dahmen, G., & Ziegler, A. (2004) · Biometrical Journal · doi:10.1002/bimj.200310018 · Cited by 61
The Net Chance of a Longer Survival as a Patient-Oriented Measure of Treatment Benefit in Randomized Clinical Trials
Péron, J., Roy, P., Ozenne, B., Roche, L., & Buyse, M. E. (2016) · JAMA Oncology · doi:10.1001/jamaoncol.2015.6359 · Cited by 62
The Correction of Myopia Evaluation Trial (COMET)
Hyman, L., Gwiazda, J. E., Marsh‐Tootle, W. L., Norton, T. T., & Hussein, M. (2001) · Controlled Clinical Trials · doi:10.1016/s0197-2456(01)00156-8 · Cited by 62
Design and methodology of the Occluded Artery Trial (OAT)
Hochman, J. S., Lamas, G. A., Knatterud, G. L., Buller, C. E. H., Džavík, V., Mark, D. B., Reynolds, H. R., & White, H. D. (2005) · American Heart Journal · doi:10.1016/j.ahj.2005.07.002 · Cited by 62
Phase III Study of N,N-Diethyl-2-[4-(Phenylmethyl) Phenoxy]Ethanamine (BMS-217380-01) Combined With Doxorubicin Versus Doxorubicin Alone in Metastatic/Recurrent Breast Cancer: National Cancer Institute of Canada Clinical Trials Group Study MA.19
Reyno, L. M., Seymour, L., Tu, D., Dent, S. F., Gelmon, K. A., Walley, B. A., Pluzanska, A., Gorbunova, V. A., Garin, A., Jassem, J., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2003.04.075 · Cited by 62
Benefits of stroke treatment delivered using a mobile stroke unit trial
Yamal, J., Rajan, S. S., Parker, S. A., Jacob, A. P., Gonzalez, M. O., Gonzales, N. R., Bowry, R., Barreto, A. D., Wu, T., Lairson, D. R., et al. (2017) · International Journal of Stroke · doi:10.1177/1747493017711950 · Cited by 61
Type I error in sample size re‐estimations based on observed treatment difference
Shun, Z., Yuan, W., Brady, W. E., & Hsu, H. (2001) · Statistics in Medicine · doi:10.1002/sim.531 · Cited by 61
A Multicenter, Randomized, Controlled Trial of Osteopathic Manipulative Treatment on Preterms
Cerritelli, F., Pizzolorusso, G., Renzetti, C., Cozzolino, V., D’Orazio, M., Lupacchini, M., Marinelli, B., Accorsi, A., Lucci, C., Lancellotti, J., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0127370 · Cited by 61
A decade of progress in statistical methodology for clinical trials
Simon, R. M. (1991) · Statistics in Medicine · doi:10.1002/sim.4780101203 · Cited by 62
Information and information fractions for design and sequential monitoring of clinical trials
Lan, K. K. G., Reboussin, D. M., & DeMets, D. L. (1994) · Communication in Statistics- Theory and Methods · doi:10.1080/03610929408831263 · Cited by 61
Self-citation
Letrozole in the extended adjuvant setting: MA.17
Goss, P. E. (2007) · Breast Cancer Research and Treatment · doi:10.1007/s10549-007-9698-1 · Cited by 60
Efficacy and Safety of Exercise Training in Patients With Chronic Heart Failure
O’Connor, C. M., Whellan, D. J., Lee, K. L., Keteyian, S. J., Cooper, L. S., Ellis, S. J., Leifer, E., Kraus, W. E., Kitzman, D. W., Blumenthal, J. A., et al. (2017) · Cited by 60
Insulin secretagogues for prevention or delay of type 2 diabetes mellitus and its associated complications in persons at increased risk for the development of type 2 diabetes mellitus
Hemmingsen, B., Sonne, D. P., Metzendorf, M., & Richter, B. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012151.pub2 · Cited by 76
International Study of Comparative Health Effectiveness with Medical and Invasive Approaches–Chronic Kidney Disease (ISCHEMIA-CKD): Rationale and design
Bangalore, S., Maron, D. J., Fleg, J. L., O’Brien, S. M., Herzog, C. A., Stone, G. W., Mark, D. B., Spertus, J. A., Alexander, K. P., Sidhu, M. S., et al. (2018) · American Heart Journal · doi:10.1016/j.ahj.2018.07.023 · Cited by 63
Benefits and harms of aspirin desensitization for aspirin‐exacerbated respiratory disease: a systematic review and meta‐analysis
Chu, D. K., Lee, D. J., Lee, K. M., Schünemann, H. J., Szczeklik, W., & Lee, J. M. (2019) · International Forum of Allergy & Rhinology · doi:10.1002/alr.22428 · Cited by 63
The Data and Safety Monitoring Board and Acquired immune deficiency syndrome (AIDS) clinical trials
DeMets, D. L., Fleming, T. R., Whitley, R. J., Childress, J. F., Ellenberg, S. S., Foulkes, M. A., Mayer, K. H., O'Fallon, J. R., Pollard, R. B., Rahal, J. J., et al. (1995) · Controlled Clinical Trials · doi:10.1016/s0197-2456(95)00073-9 · Cited by 60
Self-citation
A randomised trial of anti-GM-CSF otilimab in severe COVID-19 pneumonia (OSCAR)
Patel, J., Bass, D., Beishuizen, A., Ruiz, X. B., Boughanmi, H., Cahn, A. P., Colombo, H. R., Criner, G. J., Davy, K., de Miguel‐Díez, J., et al. (2022) · European Respiratory Journal · doi:10.1183/13993003.01870-2021 · Cited by 59
The advantages and disadvantages of adaptive designs for clinical trials
Bauer, P., & Brannath, W. (2004) · Drug Discovery Today · doi:10.1016/s1359-6446(04)03023-5 · Cited by 59
An Investigation of the Shortcomings of the CONSORT 2010 Statement for the Reporting of Group Sequential Randomised Controlled Trials: A Methodological Systematic Review
Stevely, A. K., Dimairo, M., Todd, S., Julious, S. A., Nicholl, J. P., Hind, D., & Cooper, C. L. (2015) · PLoS ONE · doi:10.1371/journal.pone.0141104 · Cited by 60
The pediatric hydroxyurea phase III clinical trial (BABY HUG): Challenges of study design
Thompson, B. W., Miller, S. T., Rogers, Z. R., Rees, R. C., Ware, R. E., Waclawiw, M. A., Iyer, R. V., Casella, J. F., Luchtman‐Jones, L., RANA, S. R., et al. (2009) · Pediatric Blood & Cancer · doi:10.1002/pbc.22269 · Cited by 59
Rationale and design of the Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT) trial
Bostom, A. G., Carpenter, M. A., Kusek, J. W., Hunsicker, L. G., Pfeffer, M. A., Levey, A. S., Jacques, P. F., & McKenney, J. L. (2006) · American Heart Journal · doi:10.1016/j.ahj.2006.03.004 · Cited by 59
The alpha spending function approach to interim data analyses
DeMets, D. L., & Lan, G. (1995) · Cancer Treatment and Research · doi:10.1007/978-1-4615-2009-2_1 · Cited by 58
Self-citation
Oral High-Dose Multivitamins and Minerals After Myocardial Infarction
Lamas, G. A., Boineau, R., Goertz, C., Mark, D. B., Rosenberg, Y., Stylianou, M. P., Rozema, T. C., Nahin, R. L., Lindblad, L., Lewis, E. F., et al. (2013) · Annals of Internal Medicine · doi:10.7326/0003-4819-159-12-201312170-00004 · Cited by 59
CArdiovascular Safety of Febuxostat and Allopurinol in Patients With Gout and Cardiovascular ComoRbiditiES
White, W. B., Chohan, S., Dabholkar, A., Hunt, B., & Jackson, R. (2012) · American Heart Journal · doi:10.1016/j.ahj.2012.04.011 · Cited by 58
Comparison of Bayesian and frequentist group-sequential clinical trial designs
Stallard, N., Todd, S., Ryan, E., & Gates, S. (2020) · BMC Medical Research Methodology · doi:10.1186/s12874-019-0892-8 · Cited by 57
A comment on futility monitoring
Freidlin, B., & Korn, E. L. (2002) · Controlled Clinical Trials · doi:10.1016/s0197-2456(02)00218-0 · Cited by 57
Capecitabine versus S-1 as adjuvant chemotherapy for patients with stage III colorectal cancer (JCOG0910): an open-label, non-inferiority, randomised, phase 3, multicentre trial
Hamaguchi, T., Shimada, Y., Mizusawa, J., Kinugasa, Y., Kanemitsu, Y., Ohue, M., Fujii, S., Takiguchi, N., Yatsuoka, T., Takii, Y., et al. (2017) · The Lancet. Gastroenterology & hepatology · doi:10.1016/s2468-1253(17)30297-2 · Cited by 57
Sample size determination for group sequential clinical trials with immediate response
Kim, K., & DeMets, D. L. (1992) · Statistics in Medicine · doi:10.1002/sim.4780111012 · Cited by 57
Self-citation
Data Monitoring Committees and Interim Monitoring Guidelines
Freidlin, B., Korn, E. L., & George, S. L. (1999) · Controlled Clinical Trials · doi:10.1016/s0197-2456(99)00017-3 · Cited by 57
Meta-analysis to integrate effect sizes within an article: Possible misuse and Type I error inflation.
Ueno, T., Fastrich, G. M., & Murayama, K. (2016) · Journal of Experimental Psychology General · doi:10.1037/xge0000159 · Cited by 56
The ability of filgrastim to mitigate mortality following LD50/60 total-body irradiation is administration time-dependent
Farese, A. M., Brown, C. R., Smith, C. P., Gibbs, A. M., Katz, B. P., Johnson, C. S., Prado, K. L., & MacVittie, T. J. (2014) · Health Physics · doi:10.1097/hp.0b013e3182a4dd2c · Cited by 56
The Effect of Intracoronary Infusion of Bone Marrow-Derived Mononuclear Cells on All-Cause Mortality in Acute Myocardial Infarction: Rationale and Design of the BAMI Trial
Mathur, A., Arnold, R. J., Aßmus, B., Bartunek, J., Belmans, A., Bonig, H. B., Crea, F., Dimmeler, S., Dowlut, S., Fernández‐Avilés, F., et al. (2017) · European Journal of Heart Failure · doi:10.1002/ejhf.829 · Cited by 56
P-Value Interpretation and Alpha Allocation in Clinical Trials
Moyé, L. A. (1998) · Annals of Epidemiology · doi:10.1016/s1047-2797(98)00003-9 · Cited by 56
Challenges in the design and analysis of sequentially monitored postmarket safety surveillance evaluations using electronic observational health care data
Nelson, J. C., Cook, A. J., Yu, O., Dominguez, C., Zhao, S., Greene, S. K., FIREMAN, B. H., Jacobsen, S. J., Weintraub, E., & Jackson, L. A. (2012) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.2324 · Cited by 55
FDA Approval Summary: Olaparib in Combination With Abiraterone for Treatment of Patients With BRCA -Mutated Metastatic Castration-Resistant Prostate Cancer
Fallah, J., Xu, J., Weinstock, C., Brave, M. H., Bloomquist, E. W., Fiero, M. H., Schaefer, T., Pathak, A. B., Abukhdeir, A. M., Bhatnagar, V., et al. (2023) · Journal of Clinical Oncology · doi:10.1200/jco.23.01868 · Cited by 56

Authors: GORDON LAN, K. K., & DEMETS, D. L.
Affiliations: University of Wisconsin–Madison (US)
Venue: Biometrika
Publisher: Oxford University Press (OUP)
Published: 1983
Volume: 70
Issue: 3
Pages: 659-663
ISSN: 0006-3444 (ISSN-L)
1464-3510
DOI: 10.1093/biomet/70.3.659
OpenAlex: W1990639292
Cited by: 2,310
References: 10
Citations by year: 2026: 51 · 2025: 69 · 2024: 80 · 2023: 78 · 2022: 63 · 2021: 73 · 2020: 77 · 2019: 96 · 2018: 76 · 2017: 89 · 2016: 90 · 2015: 72 · 2014: 112 · 2013: 73 · 2012: 101
FWCI: 7.06
Type: journal article
Language: en
Open access: closed
Locations: Biometrika (publishedVersion)
Topics: Physical Sciences › Mathematics › Statistics and Probability › Statistical Methods in Clinical Trials
Physical Sciences › Mathematics › Statistics and Probability › Probability and Statistical Research
Physical Sciences › Mathematics › Statistics and Probability › Statistical Methods and Bayesian Inference
Keywords: clinical trials, early stopping, alpha spending functions, sequential analysis, decision time, error rate control

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Discrete sequential boundaries for clinical trials

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks